Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3852124

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.c1cnc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)nc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.57
DYRK1A Q13627 3/20 0.46
CYP3A4 P08684 10/20 0.46
HPGD P15428 1/20 0.46
CYP1A2 P05177 9/20 0.46
CLK4 Q9HAZ1 9/20 0.46
ALDH1A1 P00352 7/20 0.46
CYP2D6 P10635 5/20 0.46
MAPK1 P28482 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
LMNA P02545 3/20 0.46
ALOX15 P16050 2/20 0.46
KDM4E B2RXH2 1/20 0.46
USP2 O75604 6/20 0.43
HIF1A Q16665 5/20 0.43
CYP2C19 P33261 4/20 0.43
TSHR P16473 3/20 0.43
HSD17B10 Q99714 5/20 0.43
KIT P10721 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3850032 0.90 AKT1 (0.53) AKT1DYRK1ACYP3A4HPGDCYP1A2
Trifluoroacetic Acid SCHEMBL3851562 0.88 AKT1 (0.55) AKT1DYRK1ACYP3A4HPGDCYP1A2
Trifluoroacetic Acid SCHEMBL3846124 0.86 AKT1 (0.53) AKT1DYRK1ACYP3A4HPGDCYP1A2
Trifluoroacetic Acid SCHEMBL3848208 0.86 AKT1 (0.53) AKT1DYRK1ACYP3A4HPGDCYP1A2
Trifluoroacetic Acid SCHEMBL5852383 0.86 AKT1 (0.55) AKT1DYRK1ACYP3A4HPGDCYP1A2
Trifluoroacetic Acid SCHEMBL3845037 0.86 AKT1 (0.53) AKT1DYRK1ACYP3A4HPGDCYP1A2
Trifluoroacetic Acid SCHEMBL3847329 0.86 AKT1 (0.53) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3847292 0.85 AKT1 (0.65) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3845878 0.85 AKT1 (0.56) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3855290 0.85 AKT1 (0.54) AKT1CYP3A4HPGDCYP1A2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed